Marco Quarta is the co-founder and CEO of Rubedo Life Science, a startup that develops drugs that target aging. Their lead program is a senolytic prodrug that targets senescent cells in a targeted manner.
Marco Quarta is the co-founder and CEO of Rubedo Life Science, a startup that develops drugs that target aging. Their lead program is a senolytic prodrug that targets senescent cells in a targeted manner.